MedTrace Logo

Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

NCT05340959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2023-10-03

No results posted yet for this study

Summary

A prospective observational study guided by the guidelines of Strengthening The Reporting Of Observational Study in Epidemiology (STROBE) in 2014, that will be conducted to evaluate implant stability using three devices; Osstell®, Peiotest® and AnyCheck® and comparing the results.

Conditions

  • Edentulous Alveolar Ridge

Interventions

DEVICE

Devices: Osstell®, Periotest® and AnyCheck®.

1. Osstell®: is a device that measure implant stability and based on resonance frequency analysis (RFA). Due to stiffness in the interface between the implant surface and the bone smart peg will vibrates accordingly. the more dense bone the higher stability, the higher frequency and higher Implant Stability Quotient (ISQ) value which is from 1-100. 2. Periotest®: is a device used to assess osseointegration of dental implants, so it measure implant stability . it is based on damping effect of implant. Showing the measurement digitally on a scale from -8 (low mobility) to 50 (high mobility) PTV units. 3. AnyCheck®: this is an implant stability meter that measures the stiffness of alveolar bone-implant interface through a tapping motion. Showing the measurement on a scale from 30 (low stability) to 85 (high stability).

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Alamin Y. Dhahi, B.D.S · University of Baghdad

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2022-09-01
Completion
2022-12-01

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05340959 on ClinicalTrials.gov